Meaningful positive changes in fundamentals have recently occurred for GSK plc (NYSE: GSK): the consensus estimate for December, 2023 increased significantly, significant quarterly sales acceleration occurred, and the consensus estimate for December, 2024 increased significantly.
GSK plc (NYSE: GSK) has recently enjoyed significant positive changes in investment behavior: its shorter term price trend turned up.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, GSK is expected to continue to be a major Value Builder.
GSK plc has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. GSK plc has a slightly negative Appreciation Score of 40 but a slightly positive Power Rating of 67, triggering the Neutral Value Trend Rating.
Recent Price Action
GSK plc (NYSE: GSK) stock closed at $36.98 on 12/14/23 after a modest gain of 0.7%. Moreover, trading volume in this advance was above average at 120% of normal. The stock has risen 2.2% during the last week and has been strong relative to the market over the last nine months.
Be the first to comment